Clinical trial
Prospective Randomized Comparative Study Evaluating Functional and Perioperative Outcomes After Thulium Laser Enucleation of the Prostate (ThuLEP) Versus Holmium Laser Enucleation of the Prostate (HoLEP)
NCT07565961 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Comparative Study Evaluating Functional and Perioperative Outcomes After Thulium Laser Enucleation of the Prostate (ThuLEP) Versus Holmium Laser Enucleation of the Prostate (HoLEP)
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 5, 2026
- Completion date
- December 31, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bph (benign prostatic hyperplasia)